Literature DB >> 21867682

Endoplasmic reticulum is a main localization site of mTORC2.

Delphine R Boulbés1, Tattym Shaiken, Dos D Sarbassov.   

Abstract

The Akt kinase is a critical effector in growth factor signaling. Activation of Akt driven by the growth factor dependent PI3K (phosphatidylinositol-3-OH kinase) is coupled to the plasma membrane translocation and phosphorylation of Akt on two sites by PDK1 (phosphoinositide-dependent protein kinase-1) on Thr-308 and by mTORC2 (mammalian Target of Rapamycin Complex 2) on Ser-473. In our study we examined the sub-cellular localization of mTORC2 and identified that this kinase complex predominantly resides on endoplasmic reticulum (ER). Our immunostaining analysis did not show a substantial co-localization of the mTORC2 component rictor with Golgi, lysosome, clathrin-coated vesicles, early endosomes, or plasma membrane but indicated a strong co-localization of rictor with ribosomal protein S6 and ER marker. Our biochemical study also identified the mTORC2 components rictor, SIN1, and mTOR as the highly abundant proteins in the ER fraction, whereas only small amount of these proteins are detected in the plasma membrane and cytosolic fractions. We found that growth factor signaling does not alter the ER localization of mTORC2 and also does not induce its translocation to the plasma membrane. Based on our study we suggest that the mTORC2-dependent phosphorylation of Akt on Ser-473 takes place on the surface of ER.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21867682      PMCID: PMC3225125          DOI: 10.1016/j.bbrc.2011.08.034

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Regulation of early endocytic vesicle motility and fission in a reconstituted system.

Authors:  Eustratios Bananis; John W Murray; Richard J Stockert; Peter Satir; Allan W Wolkoff
Journal:  J Cell Sci       Date:  2003-05-20       Impact factor: 5.285

2.  mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide.

Authors:  Won Jun Oh; Chang-chih Wu; Sung Jin Kim; Valeria Facchinetti; Louis-André Julien; Monica Finlan; Philippe P Roux; Bing Su; Estela Jacinto
Journal:  EMBO J       Date:  2010-11-02       Impact factor: 11.598

3.  Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.

Authors:  Robbie Loewith; Estela Jacinto; Stephan Wullschleger; Anja Lorberg; José L Crespo; Débora Bonenfant; Wolfgang Oppliger; Paul Jenoe; Michael N Hall
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

4.  ER stress inhibits mTORC2 and Akt signaling through GSK-3β-mediated phosphorylation of rictor.

Authors:  Chien-Hung Chen; Tattym Shaikenov; Timothy R Peterson; Rakhan Aimbetov; Amangeldy K Bissenbaev; Szu-Wei Lee; Juan Wu; Hui-Kuan Lin; Dos D Sarbassov
Journal:  Sci Signal       Date:  2011-02-22       Impact factor: 8.192

Review 5.  mTOR: from growth signal integration to cancer, diabetes and ageing.

Authors:  Roberto Zoncu; Alejo Efeyan; David M Sabatini
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12-15       Impact factor: 94.444

6.  FKBP12-rapamycin-associated protein or mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the Golgi apparatus.

Authors:  Ryan M Drenan; Xiangyu Liu; Paula G Bertram; X F Steven Zheng
Journal:  J Biol Chem       Date:  2003-10-24       Impact factor: 5.157

7.  EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motif.

Authors:  F T Mu; J M Callaghan; O Steele-Mortimer; H Stenmark; R G Parton; P L Campbell; J McCluskey; J P Yeo; E P Tock; B H Toh
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

8.  The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential.

Authors:  N N Ahmed; T F Franke; A Bellacosa; K Datta; M E Gonzalez-Portal; T Taguchi; J R Testa; P N Tsichlis
Journal:  Oncogene       Date:  1993-07       Impact factor: 9.867

Review 9.  Structural aspects of Golgi function.

Authors:  R S Polishchuk; A A Mironov
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

10.  Retention and retrieval: both mechanisms cooperate to maintain calreticulin in the endoplasmic reticulum.

Authors:  B Sönnichsen; J Füllekrug; P Nguyen Van; W Diekmann; D G Robinson; G Mieskes
Journal:  J Cell Sci       Date:  1994-10       Impact factor: 5.285

View more
  37 in total

1.  Protein disulfide isomerase is required for platelet-derived growth factor-induced vascular smooth muscle cell migration, Nox1 NADPH oxidase expression, and RhoGTPase activation.

Authors:  Luciana A Pescatore; Diego Bonatto; Fábio L Forti; Amine Sadok; Hervé Kovacic; Francisco R M Laurindo
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

2.  Lysosome Positioning Influences mTORC2 and AKT Signaling.

Authors:  Rui Jia; Juan S Bonifacino
Journal:  Mol Cell       Date:  2019-05-23       Impact factor: 17.970

Review 3.  Turning off AKT: PHLPP as a drug target.

Authors:  Alexandra C Newton; Lloyd C Trotman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

4.  Rapid mitogenic regulation of the mTORC1 inhibitor, DEPTOR, by phosphatidic acid.

Authors:  Mee-Sup Yoon; Christina L Rosenberger; Cong Wu; Nga Truong; Jonathan V Sweedler; Jie Chen
Journal:  Mol Cell       Date:  2015-04-30       Impact factor: 17.970

5.  HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer.

Authors:  Delphine R Boulbes; Stefan T Arold; Gaurav B Chauhan; Korina V Blachno; Nanfu Deng; Wei-Chao Chang; Quanri Jin; Tzu-Hsuan Huang; Jung-Mao Hsu; Samuel W Brady; Chandra Bartholomeusz; John E Ladbury; Steve Stone; Dihua Yu; Mien-Chie Hung; Francisco J Esteva
Journal:  Mol Oncol       Date:  2014-11-11       Impact factor: 6.603

6.  mTORC2 regulates cardiac response to stress by inhibiting MST1.

Authors:  Sebastiano Sciarretta; Peiyong Zhai; Yasuhiro Maejima; Dominic P Del Re; Narayani Nagarajan; Derek Yee; Tong Liu; Mark A Magnuson; Massimo Volpe; Giacomo Frati; Hong Li; Junichi Sadoshima
Journal:  Cell Rep       Date:  2015-04-02       Impact factor: 9.423

7.  The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2.

Authors:  Chien-Hung Chen; Dos D Sarbassov
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

8.  mTORC2 regulates mechanically induced cytoskeletal reorganization and lineage selection in marrow-derived mesenchymal stem cells.

Authors:  Buer Sen; Zhihui Xie; Natasha Case; William R Thompson; Gunes Uzer; Maya Styner; Janet Rubin
Journal:  J Bone Miner Res       Date:  2014-01       Impact factor: 6.741

Review 9.  Targeting the mTOR signaling network for Alzheimer's disease therapy.

Authors:  Chong Wang; Jin-Tai Yu; Dan Miao; Zhong-Chen Wu; Meng-Shan Tan; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-07-14       Impact factor: 5.590

10.  Chemical genetics of rapamycin-insensitive TORC2 in S. cerevisiae.

Authors:  Joseph I Kliegman; Dorothea Fiedler; Colm J Ryan; Yi-Fan Xu; Xiao-Yang Su; David Thomas; Max C Caccese; Ada Cheng; Michael Shales; Joshua D Rabinowitz; Nevan J Krogan; Kevan M Shokat
Journal:  Cell Rep       Date:  2013-12-19       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.